What's new

Human medicines European public assessment report (EPAR): Zostavax, shingles (herpes zoster) vaccine (live), Date of authorisation: 19/05/2006, Revision: 33, Status: Withdrawn

Human medicines European public assessment report (EPAR): Zostavax, shingles (herpes zoster) vaccine (live), Date of authorisation: 19/05/2006, Revision: 33, Status: Withdrawn

Jun 11, 2025 - 11:05
 0
Human medicines European public assessment report (EPAR): Zostavax, shingles (herpes zoster) vaccine (live), Date of authorisation: 19/05/2006, Revision: 33, Status: Withdrawn
Human medicines European public assessment report (EPAR): Zostavax, shingles (herpes zoster) vaccine (live), Date of authorisation: 19/05/2006, Revision: 33, Status: Withdrawn
Read More

Tags:

Previous Article

14th industry stakeholder platform on research and development support, European...

Next Article

EMEA-003485-PIP01-23

Related Posts

Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

EMEA-003561-PIP01-23

EMEA-003561-PIP01-23

Jun 11, 2025  0

Orphan designation: recombinant adeno-associated viral vector serotype 5 encoding Staphylococcus aureus Cas9 endonuclease and two guide RNAs complementary to two regions of intron 26 of the CEP290 gene Treatment of Leber's congenital amaurosis, 16/10/2017 Withdrawn

Orphan designation: recombinant adeno-associated viral ...

Jun 6, 2025  0